Tobias Engler

Otfried Müller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system.

AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system.

Journal: Journal of medical systems

Published: February 20, 2026

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study.

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study.

Journal: Archives of gynecology and obstetrics

Published: December 12, 2025

Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area.

Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area.

Journal: Archives of gynecology and obstetrics

Published: December 12, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort Analysis.

Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort Analysis.

Journal: Clinical breast cancer

Published: October 08, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

Between research and introduction to clinical routine-Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis).

Between research and introduction to clinical routine-Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis).

Journal: Archives of gynecology and obstetrics

Published: September 11, 2025

HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry.

HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry.

Journal: Journal for immunotherapy of cancer

Published: August 04, 2025

High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in Germany.

High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in Germany.

Journal: Geburtshilfe und Frauenheilkunde

Published: July 20, 2025

Management and natural course of CIN 1 and CIN 2 before and after implementation of the revised cervical cancer screening in Germany.

Management and natural course of CIN 1 and CIN 2 before and after implementation of the revised cervical cancer screening in Germany.

Journal: Archives of gynecology and obstetrics

Published: July 15, 2025

Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies.

Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor Therapies.

Journal: Geburtshilfe und Frauenheilkunde

Published: July 12, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026